Cargando…
Feasibility of Photodynamic Therapy for Glioblastoma with the Mitochondria-Targeted Photosensitizer Tetramethylrhodamine Methyl Ester (TMRM)
One of the most challenging problems in the treatment of glioblastoma (GBM) is the highly infiltrative nature of the disease. Infiltrating cells that are non-resectable are left behind after debulking surgeries and become a source of regrowth and recurrence. To prevent tumor recurrence and increase...
Autores principales: | Vasilev, Alex, Sofi, Roba, Smith, Stuart J., Rahman, Ruman, Teschemacher, Anja G., Kasparov, Sergey |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8533469/ https://www.ncbi.nlm.nih.gov/pubmed/34680569 http://dx.doi.org/10.3390/biomedicines9101453 |
Ejemplares similares
-
Using Light for Therapy of Glioblastoma Multiforme (GBM)
por: Vasilev, Alex, et al.
Publicado: (2020) -
Viral Vectors as Gene Therapy Agents for Treatment of Glioblastoma
por: Mozhei, Oleg, et al.
Publicado: (2020) -
Structure of an RNA aptamer in complex with the fluorophore tetramethylrhodamine
por: Duchardt-Ferner, Elke, et al.
Publicado: (2020) -
Simultaneous evaluation of substrate-dependent oxygen consumption rates and mitochondrial membrane potential by TMRM and safranin in cortical mitochondria
por: Chowdhury, Subir Roy, et al.
Publicado: (2016) -
Mitochondria
Targeted Protein-Ruthenium Photosensitizer
for Efficient Photodynamic Applications
por: Chakrabortty, Sabyasachi, et al.
Publicado: (2017)